SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:DiVA.org:uu-404713"
 

Sökning: onr:"swepub:oai:DiVA.org:uu-404713" > Patient characteris...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00003618naa a2200397 4500
001oai:DiVA.org:uu-404713
003SwePub
008200226s2019 | |||||||||||000 ||eng|
009oai:prod.swepub.kib.ki.se:142770983
024a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4047132 URI
024a https://doi.org/10.1097/MBC.00000000000008462 DOI
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:1427709832 URI
040 a (SwePub)uud (SwePub)ki
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Ekstrand, Charlottau Karolinska Institutet4 aut
2451 0a Patient characteristics when starting treatment and patterns of treatment in adults with chronic immune thrombocytopenia
264 1b LIPPINCOTT WILLIAMS & WILKINS,c 2019
338 a print2 rdacarrier
520 a Asymptomatic patients with primary chronic immune thrombocytopenia (ITP) are not recommended treatment if their platelet counts are above 30 x 10(9)/l. Factors such as age and comorbidities may influence clinical manifestations and should be considered for treatment decisions. The aim of this study was to determine the impact of clinical characteristics for initiation of ITP treatment, and the patterns of ITP treatment given. We performed an observational cohort study in Sweden with information from medical records and National Health Registers. Adults diagnosed with incident primary ITP between years 2009 and 2016 were included. Multinomial logistic regression was used to assess the impact of factors predicting treatment start. Out of 858 patients with chronic ITP from 71 hospitals we identified 585 (68%) with a first ITP treatment. For 537 (92%) corticosteroids were the first choice. The median platelet counts at start of treatment was 12 x 10(9)/l (interquartile range 5-27 x 10(9)/l). The variables predicting treatment start were platelet counts below 20 x 10(9)/l and treatment with antihypertensive drugs. Patients with diabetes were less likely to receive corticosteroids. Severe bleeding occurred in 75 (13%) of the patients. Platelet counts below 20 x 10(9)/l, antihypertensive treatment and bleedings were the strongest predictors of treatment start, diabetes yielded lower odds to start corticosteroid treatment. The majority of the patients had corticosteroids as first treatment while second treatment was diverse. Asymptomatic thrombocytopenia is not considered a reason as such for initiating treatment. In the latter years, splenectomy seemed to occur later in the course of treatment.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Hematologi0 (SwePub)302022 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Hematology0 (SwePub)302022 hsv//eng
653 a comorbidities and treatment start
653 a immune thrombocytopenia treatment start
653 a treatment patterns
700a Linder, Marieu Karolinska Institutet4 aut
700a Cherif, Honaru Uppsala universitet,Hematologi4 aut0 (Swepub:uu)honch489
700a Kieler, Helleu Karolinska Institutet4 aut
700a Bahmanyar, Shahramu Karolinska Institutet4 aut
710a Karolinska Institutetb Hematologi4 org
773t Blood Coagulation and Fibrinolysisd : LIPPINCOTT WILLIAMS & WILKINSg 30:7, s. 350-356q 30:7<350-356x 0957-5235x 1473-5733
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-404713
8564 8u https://doi.org/10.1097/MBC.0000000000000846
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:142770983

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy